54 related articles for article (PubMed ID: 16609002)
1. Does Duration of Adverse Events Matter in Cancer Clinical Trials?
Zhang S; Li W
J Clin Oncol; 2024 Jul; 42(19):2358. PubMed ID: 38657188
[No Abstract] [Full Text] [Related]
2. Investigating the Benefits of Collecting Low- and Moderate-Grade Adverse Events in Cancer Clinical Trials.
Selukar S
J Clin Oncol; 2024 Jul; 42(19):2358-2359. PubMed ID: 38657182
[No Abstract] [Full Text] [Related]
3. Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeed.
Nelson B; Faquin W
Cancer Cytopathol; 2024 Jun; 132(6):331-332. PubMed ID: 38829676
[No Abstract] [Full Text] [Related]
4. Youth has no age: cancer treatment for older Americans.
Paller CJ; Rudin CM
Oncology (Williston Park); 2010 Nov; 24(12):1114, 1118, 1120. PubMed ID: 21141692
[No Abstract] [Full Text] [Related]
5. Increasing entry of the elderly into cancer clinical trials: difficult, but unquestionably necessary.
Markman M
Oncology; 2007; 72(1-2):2-3. PubMed ID: 17971678
[No Abstract] [Full Text] [Related]
6. Cancer chemotherapy in elderly cancer patients.
Balducci L
J Oncol Manag; 2005; 14(2):35-8. PubMed ID: 16018197
[TBL] [Abstract][Full Text] [Related]
7. Baseline heart rate-corrected QT and eligibility for clinical trials in oncology.
Varterasian M; Meyer M; Fingert H; Radlowski D; Asbury P; Zhou X; Healey D
J Clin Oncol; 2003 Sep; 21(17):3378-9. PubMed ID: 12947082
[No Abstract] [Full Text] [Related]
8. Geriatric oncology aims for clinical trials.
Sinha G
J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
[No Abstract] [Full Text] [Related]
9. Cancer treatment and the older patient.
Trimble EL; Christian MC
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1956-7. PubMed ID: 16609002
[No Abstract] [Full Text] [Related]
10. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
Lichtman SM; Wildiers H; Chatelut E; Steer C; Budman D; Morrison VA; Tranchand B; Shapira I; Aapro M;
J Clin Oncol; 2007 May; 25(14):1832-43. PubMed ID: 17488981
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials of parenteral antineoplastic agents.
Cusack G
J Intraven Nurs; 1998; 21(6):339-43. PubMed ID: 10392099
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
